We serve Chemical Name:1-ethyl-3,4-dihydro-2H-quinolin-7-amine CAS:303982-14-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-ethyl-3,4-dihydro-2H-quinolin-7-amine
CAS.NO:303982-14-1
Synonyms:1-ETHYL-7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE;QUI032;1-ethyl-1,2,3,4-tetrahydroquinolin-7-amine;7-Amino-1-ethyl-1,2,3,4-tetrahydroquinoline
Molecular Formula:C11H16N2
Molecular Weight:176.25800
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:347.372ºC at 760 mmHg
Density:1.054
Index of Refraction:1.579
PSA:29.26000
Exact Mass:176.13100
LogP:2.68750
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-ETHYL-7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-Amino-1-ethyl-1,2,3,4-tetrahydroquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-ethyl-1,2,3,4-tetrahydroquinolin-7-amine Use and application,7-Amino-1-ethyl-1,2,3,4-tetrahydroquinoline technical grade,usp/ep/jp grade.
Related News: Indonesia is suspending its visa-free travel for Chinese citizens and barring passengers who have visited mainland China in the past 14 days. 1-ethyl-3,4-dihydro-2H-quinolin-7-amine manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 1-ethyl-3,4-dihydro-2H-quinolin-7-amine supplier Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 1-ethyl-3,4-dihydro-2H-quinolin-7-amine vendor In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 1-ethyl-3,4-dihydro-2H-quinolin-7-amine factory Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.
